Loading...

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas

Phosphoinositide-3-kinase (PI3K)-α inhibitors have shown clinical activity in squamous carcinoma (SCC) of head and neck (H&N) bearing PIK3CA mutations or amplification. Studying models of therapeutic resistance we have observed that SCCs cells that become refractory to PI3Kα inhibition maintain...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Cell
Main Authors: Elkabets, Moshe, Pazarentzos, Evangelos, Juric, Dejan, Sheng, Qing, Pelossof, Raphael A., Brook, Samuel, Benzaken, Ana Oaknin, Rodon, Jordi, Morse, Natasha, Yan, Jenny Jiacheng, Liu, Manway, Das, Rita, Chen, Yan, Tam, Angela, Wang, Huiqin, Liang, Jinsheng, Gurski, Joseph M., Kerr, Darcy A., Rosell, Rafael, Teixidó, Cristina, Huang, Alan, Ghossein, Ronald A., Rosen, Neal, Bivona, Trever G., Scaltriti, Maurizio, Baselga, José
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4398915/
https://ncbi.nlm.nih.gov/pubmed/25873175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2015.03.010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!